Skip to main content
Premium Trial:

Request an Annual Quote

(Don't) Be Still My Beating Heart

At the Association for Molecular Pathology's annual meeting in San Jose last week, Harvard Medical School's Jonathan Seidman made a case for the importance of studying rare genetic variants that cause cardiomyopathy. Various genes cause different pathway mutations that lead to cardiomyopathy, Seidman said, and cardiologists can't distinguish between them. While there are several common variants, there are multiple rare variants that can significantly increase a patient's chances of suffering from the disease. Seidman pointed to a study done in India that showed that 4 percent of Indians — about 44 million people — have one rare variant that increases their risk of cardiomyopathy seven-fold. So, he added, finding which variant cardiomyopathy patients have can also be beneficial for identifying what kind of risk their family members have for developing the disease. Seidman and his team of researchers are continuing to sequence and search for novel variants. He believes the full set of genetic variants will be identified by the end of 2011 or early 2012.

The University of Chicago's Elizabeth McNally added that when it comes to testing for inherited cardiovascular diseases, researchers and clinicians have to focus on rare variants, as they tend to be unique to families, can predict risk, and can inform a physician's choice of therapy.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.